Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.17 USD | -1.67% | +3.71% | -0.80% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.80% | 224M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- INmune Bio Says UK's Regulatory Agency Approved to Begin Phase 2 Trial of XPro in Early-Onset Alzheimer's Disease